Challenger Ltd (ASX:CGF) share price down 3% on update, is it a buy?

The Challenger Ltd (ASX:CGF) share price has fallen by 3%.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Challenger Ltd (ASX: CGF) share price is currently down 2.6% after giving investors a presentation at its 2018 investor day.

A lot of the presentation focused on the changes to the retirement phase that the government is making.

The new rules will take effect on 1 July 2019. It is hoped that the Department of Social Services changes will deliver and simplicity, although the new rules are fairly similar to old rules.

One of the most important things for Challenger is that a superannuation trustee is required to develop a member retirement income strategy. Challenger is the market-leader in annuities, so it looks as though it will be the clear winner from this.

Challenger said that for its investment portfolio it would be increasing the allocation to fixed income and decreasing the allocation to property. It said that the relative attractiveness of holding property over fixed income has reduced. Fixed income is less capital intensive than property according to Challenger, which should mean that the return on equity is improved.

One new piece of information to come out of the presentation is that Challenger will be expanding into the active exchange-traded fund (ETF) market. It is planning to launch Australia's first active fixed income ETFs.

This could be a good move, there is a growing demand for ETFs because of how easy it is to invest in them and the diversification they offer. This should mean more management fees for Challenger over time. The ETFs will be launched in the first half of FY19.

Foolish takeaway

Challenger re-iterated that 'normalised' net profit before tax growth will be 8% to 12%, subject to market conditions. It's currently trading at 17x FY19's estimated earnings. This is more expensive than Challenger has been in the past, however compared to many other growth shares I think this is a very attractive price for a 10-year investment.

Motley Fool contributor Tristan Harrison owns shares of Challenger Limited. The Motley Fool Australia owns shares of and has recommended Challenger Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »